RecruitingNot ApplicableNCT05726526

CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients

A Pragmatic Randomized Controlled Trial of a CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients


Sponsor

University of Manitoba

Enrollment

340 participants

Start Date

Jun 30, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The main purpose of this trial is to determine whether the addition of the VIEWER virtual care platform to usual care will lead to a reduction in composite emergency department (ED) visits and/or hospitalizations/or increase the perceived safety of virtual care among patients and providers.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a remote monitoring app (called VIEWER) designed specifically for people with chronic kidney disease (CKD). The goal is to catch warning signs early and reduce serious events like hospitalization or rapid kidney decline. **You may be eligible if...** - You are over 18 years old - You or your caregiver can read and speak English - You or your caregiver can use a smartphone app and are willing to do so - You are considered high-risk for kidney disease complications **You may NOT be eligible if...** - You are already on dialysis or have received a kidney transplant - You are unable to use the app due to physical or cognitive limitations - You do not have access to a compatible device Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEVIEWER virtual care platform

VIEWER is a tablet based, CKD specific home telemonitoring platform developed by our team of patients and researchers that integrates data from a wireless blood pressure cuff, weigh scale, transcutaneous O2 sat monitor and wearable motion tracker via a tablet and custom app.


Locations(5)

St. Boniface Hospital

Winnipeg, Manitoba, Canada

Chronic Disease Innovation Centre, Seven Oaks Hospital

Winnipeg, Manitoba, Canada

Health Sciences Centre

Winnipeg, Manitoba, Canada

London Health Sciences Centre

London, Ontario, Canada

Scarborough Health Network - General Hospital

Scarborough Village, Ontario, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05726526


Related Trials